pindolol has been researched along with labetalol in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (50.85) | 18.7374 |
1990's | 7 (11.86) | 18.2507 |
2000's | 13 (22.03) | 29.6817 |
2010's | 9 (15.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Akamatsu, M | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Wilcox, RG | 1 |
Louis, WJ; McNeil, JJ | 1 |
Barnett, AJ; Guest, C; Kalowski, S | 1 |
Halttunen, P; Romo, M; Saarinen, P; Sarna, S | 1 |
Blankesteijn, WM; Graafsma, SJ; Hectors, MP; Olde Riekerink, EA; Rodrigues de Miranda, JF; Thien, T | 1 |
Hara, Y; Maniwa, T; Miyagishi, A; Noguchi, T | 1 |
Davidson, JM; Maurice, J; Richardson, R; Smith, ER; Walter, T | 1 |
Brown, MJ; Sanders, L | 1 |
Haffner, CA; Hughes, BA; Kendall, MJ; Lewis, HM | 1 |
Antonellis, A; Pula, K; Rivelli, M; Sybertz, EJ; Watkins, RW | 1 |
Cronin, CJ; Graham, BR; Prichard, BN; Tomlinson, B | 1 |
Imai, S; Ishibashi, T; Jin, H; Mitomi, A; Nakazawa, M; Ohta, H; Tatebe, S | 1 |
Carrageta, MO; Raftery, EB | 1 |
Fitzgerald, JD | 1 |
Calder, AA; Forbes, CD; Greer, IA; McLaren, M; Walker, JJ | 2 |
Lepäntalo, M | 2 |
Matsunaga, K; Nakamura, K; Ueda, M | 1 |
Fishbein, L; Jackson, CD | 1 |
Smirnov, GB | 1 |
Bernini, F; Cighetti, G; Corsini, A; Fumagalli, R; Galli, G; Soma, M | 1 |
Breckenridge, AM; Grimmer, SF; Orme, ML; Roberts, DH; Tsao, Y; Winstanley, PA | 1 |
Breckenridge, A; McLoughlin, GA; Roberts, DH; Tsao, Y | 1 |
Lefflerová, K; Widimský, J | 1 |
Anavekar, SN; Doyle, AE | 1 |
Calder, AA; Forbes, CD; Greer, IA; Walker, JJ | 1 |
Giorgetti, F; Re, L; Rossini, L | 1 |
Carlsen, JE; Christensen, NJ; Hartling, OJ; Svendsen, TL; Tangø, M; Trap-Jensen, J | 1 |
Bengtsson, C | 1 |
Cherenshchikova, EA; Filippov, AK; Iuzhakov, SD; Mashkovskiĭ, MD; Porotikov, VI | 1 |
Chung, DC; Laschuk, MJ | 1 |
Lowenthal, DT | 1 |
Ahuja, RC; Nelson, GI; Silke, B; Taylor, SH | 1 |
Doyle, AE | 1 |
Cho, CH; Yat, PC | 1 |
Conti, A; Forlani, A; Monopoli, A; Ongini, E | 1 |
Aubert, N; Burlet, C; Devaux, Y; Mertes, PM; Seguin, C; Siaghy, EM; Ungureanu-Longrois, D; Zannad, F | 1 |
Martínez-Gómez, MA; Medina-Hernández, MJ; Sagrado, S; Villanueva-Camañas, RM | 1 |
Arima, Y; Hasegawa, C; Izawa, H; Kumazawa, T; Lee, XP; Sato, K; Umezawa, H | 1 |
Acharya, G; Alahuhta, S; Erkinaro, T; Haapsamo, M; Kavasmaa, T; Mäkikallio, K; Ohtonen, P; Räsänen, J; Ylikauma, L | 1 |
Bao, J; Johnson, PE; Krylov, SN; Krylova, SM; Reinstein, O; Wilson, DJ | 1 |
Acharya, G; Erkinaro, T; Haapsamo, M; Kavasmaa, T; Mäkikallio, K; Räsänen, J | 1 |
7 review(s) available for pindolol and labetalol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hypertension and beta-blockers. Are they all the same?
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Labetalol; Metoprolol; Pindolol; Receptors, Adrenergic, alpha; Sotalol | 1985 |
The possible role of the ancillary properties of beta adrenoceptor antagonists in the management of angina pectoris.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Anxiety Disorders; Bronchial Spasm; Carbohydrate Metabolism; Cardiac Output; Cell Membrane; Dogs; Drug Tolerance; Heart Ventricles; Humans; Labetalol; Lipid Metabolism; Muscle Tonus; Muscle, Smooth, Vascular; Oxygen Consumption; Pindolol; Practolol; Propanolamines; Proteins; Tremor; Vasodilation; Ventricular Fibrillation | 1985 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Betablockers in the treatment of hypertension (with special emphasis on betablockers with ISA). A review.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Middle Aged; Pindolol; Propanolamines | 1988 |
The new beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Labetalol; Metoprolol; Nadolol; Oxprenolol; Pindolol; Propanolamines; Timolol | 1984 |
Hypertension and calcium antagonists.
Topics: Airway Resistance; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension; Labetalol; Pindolol; Propranolol; Verapamil | 1982 |
13 trial(s) available for pindolol and labetalol
Article | Year |
---|---|
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Timolol | 1978 |
A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Metoprolol; Middle Aged; Pindolol; Time Factors | 1979 |
Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Patient Compliance; Pindolol | 1978 |
Labetalol and pindolol in the treatment of hypertension: a comparative study.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Pulse | 1979 |
Does treatment with beta-adrenergic blocking agents cause a decrease in beta 2-adrenoceptor affinity?
Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Labetalol; Leukocytes, Mononuclear; Male; Pindolol; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta | 1992 |
Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Labetalol; Male; Physical Exertion; Pindolol; Propanolamines; Propranolol; Random Allocation | 1987 |
Beta blockade and intermittent claudication.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Female; Gait; Hemodynamics; Humans; Hypertension; Intermittent Claudication; Labetalol; Leg; Male; Metoprolol; Middle Aged; Physical Exertion; Pindolol; Propranolol; Risk | 1985 |
Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Captopril; Female; Forearm; Heart; Heart Rate; Hemodynamics; Humans; Hypertension; Labetalol; Leg; Male; Middle Aged; Myocardial Contraction; Pindolol; Regional Blood Flow; Vascular Resistance | 1987 |
Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
Topics: Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Hypertension; Intermittent Claudication; Labetalol; Leg; Male; Middle Aged; Pindolol; Random Allocation | 1987 |
Evaluation of verapamil in the treatment of hypertension.
Topics: Adult; Benzothiadiazines; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Male; Middle Aged; Pindolol; Random Allocation; Sodium Chloride Symporter Inhibitors; Verapamil | 1986 |
Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication.
Topics: Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Heart Rate; Humans; Intermittent Claudication; Labetalol; Leg; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Vascular Resistance | 1985 |
Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol and propranolol on plasma levels of adrenaline and noradrenaline.
Topics: Adrenergic beta-Antagonists; Adult; Catecholamines; Epinephrine; Humans; Labetalol; Male; Metoprolol; Norepinephrine; Pindolol; Propranolol; Stress, Psychological | 1982 |
Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
Topics: Adult; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Ethanolamines; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation | 1983 |
39 other study(ies) available for pindolol and labetalol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Cerebrovascular Disorders; Disease Susceptibility; Hypertension; Labetalol; Male; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium, Dietary | 1991 |
Effects of four beta-adrenergic receptor antagonists on male rat sexual behavior.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dose-Response Relationship, Drug; Labetalol; Male; Pindolol; Propranolol; Rats; Sexual Behavior, Animal | 1990 |
Effects of dilevalol on human atrial muscle.
Topics: Albuterol; Heart; Heart Atria; Humans; In Vitro Techniques; Labetalol; Methods; Pindolol | 1990 |
Investigation of the beta 2-agonist properties of dilevalol: metabolic effects of intravenous infusion.
Topics: Adult; Blood Glucose; Blood Pressure; Exercise; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Labetalol; Male; Pindolol; Potassium; Reference Values; Terbutaline | 1990 |
Effects of the antihypertensive dilevalol on large artery compliance in anesthetized dogs.
Topics: Animals; Aorta; Blood Pressure; Compliance; Dogs; Female; Labetalol; Male; Pindolol; Propranolol; Ultrasonography | 1987 |
Partial agonist activity of celiprolol as assessed in conscious unrestrained dogs in comparison with those of pindolol and labetalol.
Topics: Adrenergic alpha-Agonists; Animals; Celiprolol; Dogs; Dose-Response Relationship, Drug; Heart; Hemodynamics; Labetalol; Male; Pindolol; Propanolamines; Sympathetic Nervous System | 1989 |
Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Epoprostenol; Humans; Labetalol; Pindolol; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
Topics: Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Labetalol; Pindolol; Platelet Aggregation; Prazosin; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
Intrinsic beta-sympathomimetic activity of dilevalol, R, R-isomer of labetalol.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Guinea Pigs; Heart Rate; In Vitro Techniques; Labetalol; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Propranolol; Rats; Rats, Inbred Strains; Stereoisomerism; Trachea | 1985 |
[Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Pressure; Drug Therapy, Combination; Heart Rate; Humans; Hypertension; Labetalol; Oxprenolol; Oxygen Consumption; Phentolamine; Physical Endurance; Physical Exertion; Pindolol; Propranolol; Time Factors | 1986 |
Lipophilic beta-adrenoceptor antagonists stimulate cholesterol biosynthesis in human skin fibroblasts.
Topics: Adrenergic beta-Antagonists; Cholesterol; Fibroblasts; Humans; Hydroxymethylglutaryl CoA Reductases; Labetalol; Metoprolol; Pindolol; Propanolamines; Propranolol; Skin; Stereoisomerism | 1987 |
Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Atenolol; Collagen; Drug Synergism; Epoprostenol; Humans; Labetalol; Pindolol; Platelet Aggregation; Propranolol; Solubility; Sympatholytics | 1985 |
[Cholinergic antagonism by beta-blockers. I. Spectrum of interactions].
Topics: Abdominal Muscles; Acetylcholine; Adrenergic beta-Antagonists; Animals; Guinea Pigs; Heart; Ileum; Isoproterenol; Labetalol; Male; Metoprolol; Pindolol; Practolol; Propranolol; Receptors, Cholinergic; Sotalol | 1980 |
Impairment of physical performance after treatment with beta blockers and alpha blockers.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Alprenolol; Heart Rate; Humans; Hydrochlorothiazide; Labetalol; Male; Metoprolol; Physical Exertion; Pindolol; Prazosin; Propranolol; Running | 1984 |
[Role of transmembrane ion currents in the mechanism of action of beta-adrenoblockers].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart; Ion Channels; Labetalol; Oxprenolol; Pindolol; Propranolol; Rana ridibunda | 1984 |
New drugs for hypertension.
Topics: Antihypertensive Agents; Bumetanide; Diltiazem; Dipeptides; Enalapril; Guanabenz; Guanidines; Humans; Indapamide; Labetalol; Nifedipine; Pindolol; Verapamil | 1984 |
Effects of beta-adrenoceptor antagonists on portal vein hypertension and ethanol-induced gastric mucosal damage in rats.
Topics: Adrenergic beta-Antagonists; Animals; Ethanol; Gastric Mucosa; Hemodynamics; Hypertension, Portal; Labetalol; Male; Metoprolol; Nadolol; Pindolol; Propranolol; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1994 |
Beta 1 and beta 2 adrenoceptors are involved in mediating vasodilation in the human coronary artery.
Topics: Adult; Binding, Competitive; Coronary Vessels; Dinoprost; Female; Humans; In Vitro Techniques; Iodine Radioisotopes; Isoproterenol; Kinetics; Labetalol; Male; Pindolol; Receptors, Adrenergic, beta; Vasodilation | 1993 |
Consequences of labetalol administration on myocardial beta adrenergic receptors in the brain dead pig.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Brain Death; Heart; Hemodynamics; In Vitro Techniques; Kinetics; Labetalol; Myocardium; Pindolol; Receptors, Adrenergic, beta; Swine | 2000 |
Characterization of basic drug-human serum protein interactions by capillary electrophoresis.
Topics: Adrenergic beta-Antagonists; Blood Proteins; Electrophoresis, Capillary; Humans; Labetalol; Orosomucoid; Phenothiazines; Pindolol; Protein Binding; Serum Albumin; Thiazines; Ultrafiltration | 2006 |
Simultaneous determination of beta-blockers in human plasma using liquid chromatography-tandem mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Chromatography, Liquid; Humans; Labetalol; Linear Models; Metoprolol; Pindolol; Propranolol; Sensitivity and Specificity; Tandem Mass Spectrometry | 2008 |
Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Female; Fetal Hypoxia; Fetus; Heart Rate, Fetal; Hemodynamics; Hypertension; Labetalol; Norepinephrine; Pindolol; Placenta; Placental Circulation; Pregnancy; Regional Blood Flow; Sheep; Uterus; Vascular Resistance | 2009 |
Kinetic capillary electrophoresis with mass-spectrometry detection (KCE-MS) facilitates label-free solution-based kinetic analysis of protein-small molecule binding.
Topics: Alprenolol; Electrophoresis, Capillary; Kinetics; Labetalol; Mass Spectrometry; Orosomucoid; Pindolol; Propranolol; Protein Binding; Proteins; Small Molecule Libraries | 2011 |
Fetal cardiac function after labetalol or pindolol for maternal hypertension in a sheep model of increased placental vascular resistance.
Topics: Animals; Antihypertensive Agents; Female; Fetal Heart; Hypertension, Pregnancy-Induced; Hypoxia; Labetalol; Norepinephrine; Pindolol; Placental Circulation; Pregnancy; Pulmonary Circulation; Sheep; Vascular Resistance | 2013 |